Johnson & Johnson

Eli Muchtar is a hematologist at Mayo clinic, Rochester, Minnesota. He received his medical degree from Ben Gurion University of the Negev followed by residency in…

A new staging system developed with a more accessible test to predict the chance of survival in patients living with light chain (AL) amyloidosis. Led by…

Scientists at Scripps Research have identified a group of small molecules that prevent structural changes to proteins that are at the root of AL amyloidosis, a…

Prothena Corporation PLC, a clinical-stage neuroscience company, today reported final results from the Phase 3 VITAL Amyloidosis study of NEOD001 (birtamimab) in…

Updated research regarding the ANDROMEDA study presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, indicated the…

AL amyloidosis is a rare condition caused when bone marrow produces abnormal antibodies that can't be broken down and are deposited in tissues, interfering with…

Amyloidosis is a rare disease that occurs when amyloid proteins are deposited in tissues and organs. Amyloid proteins are abnormal proteins that the body cannot…

Diarrhoea is the passing of loose or watery stools more than three times a day. It can be acute (lasting only for a short time) or chronic (persisting for long…

Serum amyloid P component (SAP) is a normal protein found in the blood that binds to amyloid deposits. In healthy people there are very small amounts of SAP and…

In AL amyloidosis, an abnormal protein called amyloid is produced and accumulates in tissues and organs. The build-up of amyloid protein is called an amyloid…